Cresemba and Foscavir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cresemba (isavuconazonium sulfate) and Foscavir (foscarnet sodium). Common drug interactions include cytokine release syndrome among females and blood alkaline phosphatase increased among males.
The phase IV clinical study analyzes what interactions people have when they take Cresemba and Foscavir. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.
What is Cresemba?
Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.
What is Foscavir?
Foscavir has active ingredients of foscarnet sodium. eHealthMe is studying from 1,631 Foscavir users. Check the latest studies of Foscavir.
20 people who take Cresemba and Foscavir together, and have interactions are studied.
What are the common drug interactions of Cresemba and Foscavir, by gender? *:
female:
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Klebsiella infection
male:
- Blood alkaline phosphatase increased
- Blood bilirubin increased
- Cell death
- Gamma-glutamyltransferase increased
- Death
What are the common drug interactions of Cresemba and Foscavir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Blood alkaline phosphatase increased
- Blood bilirubin increased
- Cell death
- Gamma-glutamyltransferase increased
- Death
30-39:
n/a
40-49:
n/a
50-59:
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Klebsiella infection
60+:
n/a
What are the existing conditions these people have? *
- Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 19 people, 95.00%
- Herpes Simplex (herpes simplex is a common viral infection): 19 people, 95.00%
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 19 people, 95.00%
- Agitation (state of anxiety or nervous excitement): 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Cresemba and Foscavir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cresemba and Foscavir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cresemba:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Foscavir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cresemba and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Foscavir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on isavuconazonium sulfate and foscarnet sodium (the active ingredients of Cresemba and Foscavir, respectively), and Cresemba and Foscavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Relafen cause Crohn'S Disease? - 14 seconds ago
- Could Travatan cause Abdominal Pain Lower? - 19 seconds ago
- Could Travatan cause Abdominal Discomfort? - 34 seconds ago
- Could Fentanyl cause Myoglobinuria? - 39 seconds ago
- Could Neupogen cause Pelvic Pain? - a minute ago
- Drug interactions of Levetiracetam and Prednisolone - a minute ago
- Tylenol vs. Feldene, side effect and effectiveness comparison - a minute ago
- Could Amphotericin B cause Insomnia? - a minute ago
- Could Actemra cause Skin Discoloration? - a minute ago
- Could Amoxicillin cause Seizures? - a minute ago